Literature DB >> 36061576

Two Cases of Rectal Cancer with Retzius Shunt Treated with Robot-Assisted Surgery.

Kazushi Hara1, Manabu Yamamoto1, Shohei Sawata1, Yusuke Kono1, Kyoichi Kihara1, Tomoyuki Matsunaga1, Naruo Tokuyasu1, Teruhisa Sakamoto1, Yoshiyuki Fujiwara1.   

Abstract

The retroperitoneal intestinal vein-general circulation anastomotic pathway is referred to as a Retzius shunt; however, it is not a well-recognized condition. Here, we describe two patients with a Retzius shunt who underwent robot-assisted surgery for rectal cancer. The first case was an 81-year-old woman who had tested positive for fecal occult blood. A type 0-Is tumor was found in the middle rectum, and we used robot-assisted surgery for resection. Intraoperative findings included a dilated vein between the inferior mesenteric artery (IMA) and inferior mesenteric vein (IMV); further, computed tomography (CT) revealed flow into the inferior vena cava (IVC). We clipped the vein without major bleeding and the tumor-specific mesorectal excision was completed. Thereafter, we reviewed relevant literature and identified the structure to be a Retzius shunt. The second case was 77-year-old man with type 1 advanced cancer in the middle rectum who underwent robot-assisted surgery. In this case, we recognized the Retzius shunt on preoperative CT due to our experience with the first case and surgery was completed without any problems. Preoperative recognition of vascular malformations, such as the Retzius shunt by CT is critical to ensure the safety of robot-assisted surgery. ©2022 Tottori University Medical Press.

Entities:  

Keywords:  Retzius shunt; rectal cancer; robot-assisted surgery; venous malformation

Year:  2022        PMID: 36061576      PMCID: PMC9419219          DOI: 10.33160/yam.2022.08.003

Source DB:  PubMed          Journal:  Yonago Acta Med        ISSN: 0513-5710            Impact factor:   1.371


  9 in total

Review 1.  Portal-systemic encephalopathy due to a congenital extrahepatic portosystemic shunt: three cases and literature review.

Authors:  T Akahoshi; T Nishizaki; K Wakasugi; T Mastuzaka; K Kume; I Yamamoto; K Sugimachi
Journal:  Hepatogastroenterology       Date:  2000 Jul-Aug

2.  Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer.

Authors:  D G Jayne; H C Thorpe; J Copeland; P Quirke; J M Brown; P J Guillou
Journal:  Br J Surg       Date:  2010-11       Impact factor: 6.939

3.  Functional anatomy of the porta-systemic communications.

Authors:  E A EDWARDS
Journal:  AMA Arch Intern Med       Date:  1951-08

4.  Treatment of post-shunt portal systemic encephalopathy by embolization of the shunt.

Authors:  J M Henderson
Journal:  Hepatology       Date:  1989-01       Impact factor: 17.425

5.  Portal-systemic encephalopathy due to a congenital portocaval shunt.

Authors:  R K Kerlan; R D Sollenberger; A J Palubinskas; N H Raskin; P W Callen; W K Ehrenfeld
Journal:  AJR Am J Roentgenol       Date:  1982-11       Impact factor: 3.959

6.  Gastrointestinal hemorrhage from adhesion-related mesenteric varices.

Authors:  A C Moncure; A C Waltman; T J Vandersalm; R R Linton; F H Levine; W M Abbott
Journal:  Ann Surg       Date:  1976-01       Impact factor: 12.969

7.  Impact of conversion on the long-term outcome in laparoscopic resection of colorectal cancer.

Authors:  Albert C Y Chan; Jensen T C Poon; Joe K M Fan; Siu Hung Lo; Wai Lun Law
Journal:  Surg Endosc       Date:  2008-02-23       Impact factor: 4.584

8.  Veins of Retzius at CT during arterial portography: anatomy and clinical importance.

Authors:  K Ibukuro; T Tsukiyama; K Mori; Y Inoue
Journal:  Radiology       Date:  1998-12       Impact factor: 11.105

9.  Surgical treatment of rectal cancer with a Retzius shunt: a case report.

Authors:  Toshinori Sueda; Mitsuyoshi Tei; Haruna Furukawa; Tae Matsumura; Chikato Koga; Masaki Wakasugi; Hiromichi Miyagaki; Ryohei Kawabata; Junzo Shimizu; Atsuya Okada; Junichi Hasegawa
Journal:  Surg Case Rep       Date:  2019-02-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.